Table 2.
Adjusted multinomial regression analysis examining risk phenotype related to increased risk of first and recurrent CMV infections.
| 1 Episode, OR (95% CI) | P-value | 2+ Episodes, OR (95% CI) | P-value | |
|---|---|---|---|---|
| Age* | 1.02 (1.01, 1.03) | <0.0001 | 1.04 (1.02, 1.06) | <0.0001 |
| Race | ||||
| Other | 1.48 (1.14, 1.93) | 0.0036 | 2.69 (1.47, 4.93) | 0.0014 |
| Caucasian/White | Reference | |||
| Primary diagnosis | ||||
| Diabetes | 0.83 (0.61, 1.11) | 0.2072 | 0.45 (0.23, 0.90) | 0.0246 |
| Glomerulonephritis | 0.65 (0.49, 0.87) | 0.0030 | 0.69 (0.39, 1.24) | 0.2125 |
| Other | Reference | |||
| CMV status at baseline (D/R) | ||||
| D+/R- | 2.18 (1.50, 3.16) | <0.0001 | 4.29 (2.00, 9.16) | 0.0002 |
| D-/R+ | 0.50 (0.37, 0.67) | <0.0001 | 0.41 (0.19, 0.88) | 0.0223 |
| D-/R- | 0.03 (0.01, 0.11) | <0.0001 | 0.28 (0.06, 1.27) | 0.0983 |
| D+/R+ | Reference | |||
| Induction ATG | ||||
| Yes | 1.39 (0.98, 1.98) | 0.0628 | 1.10 (0.57, 2.14) | 0.7757 |
| No | Reference | |||
| Delayed graft function | ||||
| Yes | 1.56 (1.21, 2.02) | 0.0006 | 3.05 (1.80, 5.18) | <0.0001 |
| No | Reference | |||
| On prophylaxis | ||||
| Yes | 1.24 (0.85, 1.81) | 0.2611 | 2.05 (0.91, 4.65) | 0.0849 |
| No | Reference | |||
Reference category is No CMV episodes.
*Age at first transplantation.
CI, confidence interval; CMV, cytomegalovirus; D, donor; OR, odds ratio; R, recipient.